Cholecystectomy

SS Innovations’ Flagship SSi Mantra Surgical Robotic Device Successfully Completes Telesurgery Procedures

Retrieved on:

Wednesday, April 10, 2024

OTC, Cholecystectomy, Surgeon, Cystectomy, Patient, Prostatectomy, Medicine, Medical device

FORT LAUDERDALE, Fla., April 10, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to a global population, today announced that its SSi Mantra Surgical Robotic System has successfully completed its first-ever telesurgery procedures on an animal in India.

Key Points:

FORT LAUDERDALE, Fla., April 10, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to a global population, today announced that its SSi Mantra Surgical Robotic System has successfully completed its first-ever telesurgery procedures on an animal in India.
The surgery was conducted at the SS Innovations headquarters in Gurugram, Haryana, on an animal located five kilometers away at the World Laparoscopy Hospital.
Dr. Srivastava commented, “This is a groundbreaking moment for SS Innovations and positions the Company at the forefront of telesurgery as we work to shape the future of healthcare in India and around the world.
This successful study brings us one step closer to delivering gold standard, precision medicine to all patients, and to making telesurgery an option for surgeons and their patients in the future.”
The SSi Mantra Surgical Robotic System is clinically validated for over 50 different surgical procedures, and to date, more than 900 surgical procedures have been conducted using the system.

CMR Surgical announces over 20,000 surgical cases completed using Versius

Retrieved on:

Thursday, March 21, 2024

CMR Surgical (CMR) – the global surgical robotics business – has today announced that over 20,000 Versius surgical cases have now been completed as the Company works with hospitals and surgeons around the world to bring minimal access surgery to everyone who needs it.

Key Points:

CMR Surgical (CMR) – the global surgical robotics business – has today announced that over 20,000 Versius surgical cases have now been completed as the Company works with hospitals and surgeons around the world to bring minimal access surgery to everyone who needs it.
The Versius Surgical Robotic System is a small, modular and versatile surgical robot used for soft tissue surgery.
Over 75% of hospitals who have adopted Versius are using the system across two or more surgical specialties, leading to some hospitals around the world purchasing more than one system.
Through the Versius Connect app, Versius Trainer and CMR clinical registry, Versius unleashes a wealth of insights to ultimately improve surgical care.

CMR Surgical announces over 20,000 surgical cases completed using Versius

Retrieved on:

Thursday, March 21, 2024

CMR Surgical (CMR) – the global surgical robotics business – has today announced that over 20,000 Versius surgical cases have now been completed as the Company works with hospitals and surgeons around the world to bring minimal access surgery to everyone who needs it.

Key Points:

CMR Surgical (CMR) – the global surgical robotics business – has today announced that over 20,000 Versius surgical cases have now been completed as the Company works with hospitals and surgeons around the world to bring minimal access surgery to everyone who needs it.
The Versius Surgical Robotic System is a small, modular and versatile surgical robot used for soft tissue surgery.
Over 75% of hospitals who have adopted Versius are using the system across two or more surgical specialties, leading to some hospitals around the world purchasing more than one system.
Through the Versius Connect app, Versius Trainer and CMR clinical registry, Versius unleashes a wealth of insights to ultimately improve surgical care.

Levita® Magnetics Achieves First Deployment of MARS™ Surgical System in a Private Institution

Retrieved on:

Thursday, April 4, 2024

Bariatric surgery, Patient, Hospital, Prostate, Magnetism, Surgeon, Cleveland Clinic, Bypass surgery, Pain, Cholecystectomy, FDA, Health, Medical imaging

MOUNTAIN VIEW, Calif., April 4, 2024 /PRNewswire/ -- Levita Magnetics, whose mission is to expand patient access to advanced surgical care, today celebrates a key advancement in minimally invasive surgery with the deployment of its MARS surgical system at a North Texas-based hospital. This marks a significant milestone as the first implementation of the MARS system in a private institution, representing a critical development in the global expansion of the technology. This expansion follows Levita's recent international introduction in Chile and its first commercial application in the U.S. at Cleveland Clinic in late 2023.

Key Points:

This marks a significant milestone as the first implementation of the MARS system in a private institution, representing a critical development in the global expansion of the technology.
"The introduction of the MARS system in Dallas represents a meaningful and impactful advancement in our surgical capabilities," said Dr. Chad Carlton.
The MARS system, an FDA-approved surgical platform, innovatively combines magnetic technology and machinery to minimize incisions, enhance visualization, and streamline laparoscopic surgery.
MARS builds on the clinical benefits of the Levita Magnetic Surgical System®, incorporating proprietary Dynamic Magnetic Positioning technology with dual surgeon-controlled arms.

Levita® Magnetics Leads the Future of Surgery with Augmented Reality (AR) Headset-Enhanced Abdominal Surgery

Retrieved on:

Wednesday, March 20, 2024

Growth, Environment, Meta, Software, Magnetism, Surgeon, Dream, Cholecystectomy

MOUNTAIN VIEW, Calif., March 20, 2024 /PRNewswire/ -- Levita Magnetics today announced a significant breakthrough in surgical technology through its deployment of augmented reality (AR) in abdominal surgeries. This milestone, which took place in Santiago, Chile on March 11, combined the use of Levita's MARS™ system with the Meta Quest 3 Headset, enhancing surgical performance and representing a pivotal development in the medical field by paving the way for AI-enhanced digital surgery and global telesurgery.

Key Points:

MOUNTAIN VIEW, Calif., March 20, 2024 /PRNewswire/ -- Levita Magnetics today announced a significant breakthrough in surgical technology through its deployment of augmented reality (AR) in abdominal surgeries.
The integrative landmark surgeries were conducted by Dr. Alberto Rodriguez-Navarro, a seasoned surgeon and founder and CEO of Levita Magnetics.
Dr. Rodriguez-Navarro used the MARS and AR technologies to perform a cholecystectomy, commonly known as gallbladder removal surgery – the most frequent abdominal surgery on a global scale.
This surgery is also one of the first times the lead surgeon performed a surgery while wearing an AR headset.

SS Innovations Launches Groundbreaking Inaugural Multi-Specialty Robotic Surgical Conference

Retrieved on:

Monday, January 22, 2024

Aster, Artificial intelligence, General surgery, Urology, Apollo Hospitals, The Honourable, RGCI, Hysterectomy, Cholecystectomy, Medanta, OTC, Conference, Hospital, Cystectomy, Mantra, Incisional hernia, Medical device

FORT LAUDERDALE, Fla., Jan. 22, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, is proud to have presented the inaugural SS Innovations Multi-Specialty Robotic Surgical Conference (SMRSC), that was held at The Leela Ambience Hotel in Gurugram, Haryana, India on January 19 and 20, 2024. The meeting was highly attended with more than 600 visitors over the course of two days.

Key Points:

13 Live, broadcasted surgeries were performed by distinguished multi-specialty surgeons, using the SSi Mantra Surgical Robotic System
Distinguished guests included the Honorable Governor of Haryana, Mr. Bandaru Dattatreya
FORT LAUDERDALE, Fla., Jan. 22, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, is proud to have presented the inaugural SS Innovations Multi-Specialty Robotic Surgical Conference (SMRSC), that was held at The Leela Ambience Hotel in Gurugram, Haryana, India on January 19 and 20, 2024.
SMRSC 2024 was a transformative event that brought together global medical experts, technological innovators, and visionaries to explore the future of robotic surgery, with a specific focus on SS Innovations’ flagship surgical robotic system, the SSi Mantra.
SMRSC 2024 was a productive and educational event that showcased the SSi Mantra, SS Innovations’ technologically advanced, affordable, and accessible surgical robotic system, and SSi Maya, our groundbreaking virtual and mixed reality development division that we anticipate will allow us to launch robotic programs using tele-proctoring and tele-surgery.
The conference endeavors to set the stage for the future of healthcare with the SSi Mantra Surgical Robotic System.

Levita® Magnetics Announces First International Deployment of MARS™ Surgical System

Retrieved on:

Thursday, December 7, 2023

Medicine, Prostate, Surgeon, Cleveland Clinic, Patient, FDA, Gallbladder, Magnet, Cholecystectomy, Weight loss, Magnetism, Hospital, Dentistry, Medical imaging, MARS

MOUNTAIN VIEW, Calif., Dec. 7, 2023 /PRNewswire/ -- Levita Magnetics, whose mission is to help more patients get access to better surgery, announced today the international launch of its MARS surgical system at Hospital Luis Tisne in Santiago, Chile. This marks another milestone in the global advancement of minimally invasive surgery.

Key Points:

Dr. Julio Jimenez at the Hospital Luis Tisne performed a series of procedures, including same-day discharge gallbladder removals and bariatric surgeries.
This deployment of the MARS system comes shortly after the company's first commercial use cases in the United States at the world-renowned Cleveland Clinic.
"The deployment of the MARS surgical system in Hospital Luis Tisne, an important public hospital in Santiago, Chile, marks a moment of pride for our entire team.
We will continue to push paradigm-shifting solutions across medicine in the coming months through our clinically valuable, cost and space-efficient surgical system."

The Franche-Comté Polyclinic & Moon Surgical Showcase the Maestro System's Simplicity and Ease-of-Use

Retrieved on:

Tuesday, December 5, 2023

SAN, Surgeon, Patient, Artificial intelligence, Maestro, Pain, Cholecystectomy, Learning curve, Robotics, Hernia, Dentistry, Nursing

The surgical team at the Franche-Comté Polyclinic rapidly achieved autonomy with the Maestro System, requiring support from Moon Surgical staff for just six procedures before independently managing setup and operation.

Key Points:

The surgical team at the Franche-Comté Polyclinic rapidly achieved autonomy with the Maestro System, requiring support from Moon Surgical staff for just six procedures before independently managing setup and operation.
Since then, Maestro has become a central part of our surgical practice."
"The Maestro System has been a wonderful addition to our operating room," said Dany Scheffer, who assists Dr. Mercoli at the Franche-Comté Polyclinic.
With the Maestro System, Moon Surgical empowers laparoscopy teams in these procedures with the latest technology in robotics, computer vision, and artificial intelligence.

Arnault Tzanck Institute in Nice, France, Completes Inaugural Robotics Surgeries with Moon Surgical's Maestro Commercial System

Retrieved on:

Tuesday, October 24, 2023

Weight loss, Baptist Health, Diabetes, Cholecystectomy, OR, Surgeon, Hypertension, Hospital, Sleep apnea, Maestro, Bariatric surgery, Clinique, Patient, SAN, Dentistry

PARIS and SAN FRANCISCO, Oct. 24, 2023 /PRNewswire/ -- The Arnault Tzanck Institute and Moon Surgical, a French-American pioneer in collaborative robotics, announced the successful completion of the first ten laparoscopic surgeries leveraging a new, commercially-ready Maestro System in Nice, France. The weight loss (bariatric) and abdominal surgery procedures were performed by Dr. Benjamin Cadière and Dr. Georges Debs, both laparoscopic surgeons, and mark the expansion of the hospital's bariatric practice, which aims to provide integrated care to patients at its new Clinique du Poids Idéale - a one-stop shop for weight loss.

Key Points:

PARIS and SAN FRANCISCO, Oct. 24, 2023 /PRNewswire/ -- The Arnault Tzanck Institute and Moon Surgical , a French-American pioneer in collaborative robotics, announced the successful completion of the first ten laparoscopic surgeries leveraging a new, commercially-ready Maestro System in Nice, France.
Moon Surgical's Maestro System is designed to enhance surgeons during surgical procedures by providing an extra set of arms that they can use to control two additional instruments.
"Integrating the Maestro robot was very instinctive and straightforward," said Dr. Benjamin Cadière, laparoscopic surgeon at the Institut Arnault-Tzanck.
An initial version of the Maestro System was used successfully at Baptist Health in Jacksonville, Florida, earlier in the summer.

Asensus Surgical, Inc. Reports Operating and Financial Results for the First Quarter 2023

Retrieved on:

Thursday, May 11, 2023

For the full year 2023, the Company continues to expect to initiate 10 - 12 new Senhance programs.

Key Points:

For the full year 2023, the Company continues to expect to initiate 10 - 12 new Senhance programs.
The Company received U.S. FDA 510(k) clearance for pediatric surgeries in the U.S. during the first quarter of 2023.
During the first quarter of 2023, the Company initiated one new Senhance Surgical System placement in Japan.
The Company had cash, cash equivalents, short-term and long-term investments, excluding restricted cash of approximately $57.4 million as of March 31, 2023.